Skip to main content
Signal8

MindMaze Therapeutics Holding SA (MMTZF)

Sector: Pharmaceutical Preparations

MMTZF logo

OTC:MMTZF

OTC:MMTZF
+6.58%$0.1798
Mkt Cap-
EV-
Float124.74M
O/S-
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
FormDescription
424B3
Prospectus
F-6 POS
FORM F-6 POST EFFECTIVE AMENDMENT NO. 4 TO REGISTRATION STATEMENT
424B3
RULE 424(B)(3) ADR
15F-12G
FORM 15-F NOTICE OF TERMINATION
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR DECEMBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR SEPTEMBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR SEPTEMBER, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR SEPTEMBER, 2024
6-K
Foreign Private Issuer Report
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR AUGUST, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR JUNE, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR JUNE, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR MAY, 2024
20-F
Foreign Annual Report
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR APRIL, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR MARCH, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR FEBRUARY, 2024
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR DECEMBER, 2023
6-K
FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2023

1-25 of 60

    MindMaze Therapeutics Holding SA (MMTZF) SEC Filings | Signal8